Schedule 13G ownership disclosure
Cartesian Therapeutics Inc
Common Stock, $0.0001 par value per share · CUSIP: 816212302
Event date: 2025-03-31
- Filing-level shares
- 1,675,636.0
- Percent of class
- 6.1%
- JPMORGAN CHASE & CO.
Shares: 1,675,636.0 · Class: 6.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000019617-25-000398
- Form type
- SCHEDULE 13G
- Filer
- Cartesian Therapeutics, Inc.
- CIK
- CIK 1453687
- Filed
- Apr 25, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership